Nabo Life's 2024 Annual Summary and 2025 Annual Plan Meeting was successfully held.

 During the meeting, each business leader of the company gave a comprehensive and in-depth summary of the work for 2024. Through detailed data and abundant examples, they presented the achievements made in the past year, and also candidly analyzed the problems and shortcomings in the work. In the outlook for the 2025 plan, each department clarified their work goals and priorities, proposed innovative ideas and measures, and demonstrated their confidence and determination for the new year. 
Ma Chunhui, the chairman of Nabao Life, expressed heartfelt gratitude and affirmation for the hard work of all employees at the meeting. At the same time, he emphasized that in the new year, Nabao Life will continue to uphold the development philosophy of innovation-driven and quality-first, continuously enhance the company's core competitiveness, actively expand market share, strengthen team building, and strive to achieve the company's long-term development goals. 
At the banquet, everyone, with an optimistic and determined spirit, raised their glasses together and sent out wonderful wishes for the upcoming 2025. During the banquet, there were also wonderful performances and interactive games, which further enhanced the relationship among the employees and the team cohesion. 
The successful holding of this year-end summary and planning outlook meeting as well as the banquet was not only a review and summary of Nabao Life's past year, but also an outlook and mobilization for future development. We believe that with the joint efforts of all employees, Nabao Life will surely achieve even more brilliant achievements in 2025 and reach new heights.

Nabo Life's Spring Festival Holiday Schedule for 2025

       Nabo Life currently possesses a complete chain technology platform covering antibody development, discovery, and engineering. This platform includes screening platforms such as phage display, Escherichia coli display, and mammalian cell display, as well as membrane protein preparation and mRNA immunization platforms. Through the cross-complementation of multiple platforms, it provides flexible antibody discovery and modification services for pharmaceutical companies and research institutions, assisting in the development of drugs and reagents. 
Nabo Life focuses on the development, modification and application of nanobodies. It has a breeding base of alpacas that meets the standards for laboratory animals and an independent laboratory base. It is committed to building an integrated experimental public service platform for industry, academia and research. We hope to provide more professional and cost-effective experimental services for a wide range of biological research institutions, pharmaceutical R&D enterprises and innovation teams. 
For more service details, please visit Nabao Life's official website or call 400-822-9180 for consultation!